Weekly pill could slow aging: new study tests safer doses
NCT ID NCT05949658
First seen Feb 10, 2026 · Last updated Jun 12, 2026 · Updated 18 times
Summary
This study tests whether taking a low dose of sirolimus or everolimus once a week can safely slow the aging process in healthy adults aged 55 to 89. Participants take the drug for 6 weeks, and researchers monitor side effects and drug levels in the blood. The goal is to find a dose that works without causing major problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53705, United States
Contact
Conditions
Explore the condition pages connected to this study.